{"gene":"ARFGEF2","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2003,"finding":"ARFGEF2 encodes BIG2, a brefeldin A-inhibited guanine nucleotide-exchange factor required for vesicle and membrane trafficking from the trans-Golgi network (TGN). Inhibition of BIG2 by BFA or dominant-negative ARFGEF2 cDNA decreases neural progenitor cell proliferation in vitro and disrupts intracellular localization of E-cadherin and beta-catenin by preventing their transport from the Golgi apparatus to the cell surface.","method":"Dominant-negative ARFGEF2 cDNA transfection, BFA inhibition, western blot, immunofluorescence in neural cell lines","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (dominant-negative, pharmacological inhibition, localization), replicated phenotypes","pmids":["14647276"],"is_preprint":false},{"year":2002,"finding":"BIG2 overexpression blocks BFA-induced redistribution of ARF1 and the AP-1 complex from membranes but not that of the COPI complex, indicating BIG2 specifically mediates AP-1 (but not COPI) membrane association through ARF activation at the TGN.","method":"BIG2 overexpression, BFA treatment, immunofluorescence for coat proteins","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — overexpression plus pharmacological perturbation with specific coat protein readouts, replicated by dominant-negative study","pmids":["11777925"],"is_preprint":false},{"year":2002,"finding":"A dominant-negative BIG2 mutant induces redistribution of AP-1 and GGA1 from membranes and causes TGN membrane tubulation, but does not affect COPI redistribution or Golgi membrane tubulation, placing BIG2 specifically in the TGN-to-endosome trafficking route via AP-1 and GGA coat proteins.","method":"Dominant-negative BIG2 mutant expression, immunofluorescence for coat proteins and organelle markers","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 — dominant-negative with specific coat protein readouts, consistent with parallel overexpression study","pmids":["12051703"],"is_preprint":false},{"year":2004,"finding":"A population of BIG2 localizes to recycling endosomes (in addition to TGN); expression of a catalytically inactive BIG2 E738K mutant selectively induces membrane tubules from the recycling endosome compartment. BIG2 activates class I ARFs (ARF1 and ARF3) in vivo, and inactivation of either ARF exaggerates E738K-induced tubulation, indicating BIG2 maintains recycling endosome structural integrity through class I ARF activation.","method":"Catalytically inactive mutant (E738K) expression, ARF knockdown, immunofluorescence, organelle morphology analysis","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1–2 — catalytic mutant with defined substrate specificity confirmed in vivo, genetic epistasis with ARF1/ARF3","pmids":["15385626"],"is_preprint":false},{"year":2003,"finding":"BIG2 contains three A kinase-anchoring protein (AKAP) domains: domain A (residues 27–48) interacting with RIα and RIβ, domain B (residues 284–301) interacting with RIIα and RIIβ, and domain C (residues 517–538) interacting with RIα, RIIα, and RIIβ. BIG2 co-immunoprecipitates with endogenous RIα in HepG2 cytosol, and cAMP elevation causes BIG2 translocation from cytosol to Golgi/membrane structures.","method":"Yeast two-hybrid screen, co-immunoprecipitation of in vitro translated and endogenous proteins, deletion mutagenesis, subcellular fractionation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 — yeast two-hybrid confirmed by reciprocal Co-IP of endogenous proteins plus deletion mapping of three AKAP domains","pmids":["12571360"],"is_preprint":false},{"year":2005,"finding":"BIG2 physically interacts with exocyst protein Exo70 via its N-terminal region (amino acids 1–643). Endogenous BIG2 and Exo70 co-localize at TGN membranes and the microtubule-organizing center (MTOC)/centrosomes in HepG2 cells, suggesting functional cooperation in vesicular trafficking from TGN to plasma membrane.","method":"Yeast two-hybrid, co-immunoprecipitation of in vitro translated proteins, immunofluorescence, centrosome purification","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — yeast two-hybrid confirmed by Co-IP plus subcellular fractionation/localization","pmids":["15705715"],"is_preprint":false},{"year":2006,"finding":"BIG2, but not BIG1, associates with recycling endosomes during transferrin uptake and is required for transferrin receptor (TfnR) recycling. BIG2 siRNA knockdown increases perinuclear TfnR accumulation and slows transferrin release, while BIG1 siRNA has no effect on these processes.","method":"siRNA knockdown, immunofluorescence, density-gradient fractionation, transferrin uptake/release assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — specific siRNA knockdown with functional recycling assay and fractionation confirming localization","pmids":["16477018"],"is_preprint":false},{"year":2006,"finding":"BIG2 (but not BIG1) is required for AMY-1 localization to the TGN; AMY-1 co-immunoprecipitates with both BIG1 and BIG2, but RNAi knockdown demonstrates that BIG2 specifically anchors AMY-1 at the TGN.","method":"Co-immunoprecipitation with FLAG-tagged AMY-1, RNAi knockdown, immunofluorescence","journal":"Genes to cells : devoted to molecular & cellular mechanisms","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP with RNAi confirmation, single study","pmids":["16866877"],"is_preprint":false},{"year":2007,"finding":"BIG2 (but not BIG1) regulates the constitutive release of full-length TNFR1 in exosome-like vesicles from human vascular endothelial cells via ARF1- and ARF3-dependent mechanisms. BIG2 co-localizes with TNFR1 in cytoplasmic vesicles and this association is disrupted by BFA.","method":"RNAi knockdown of BIG1/BIG2, TNFR1 release assay, ARF1/ARF3 knockdown, co-localization immunofluorescence, BFA treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — specific siRNA with functional exosome release assay, ARF substrate confirmed by knockdown epistasis","pmids":["17276987"],"is_preprint":false},{"year":2007,"finding":"PKA phosphorylates BIG2 in vitro (causing electrophoretic retardation), decreasing its ARF guanine nucleotide exchange activity; protein phosphatase 1γ (PP1γ), but not PP1α, PP1β, or PP2A, restores BIG2 GEP activity after PKA phosphorylation. Endogenous PP1γ co-immunoprecipitates with BIG2 from microsomal fractions.","method":"In vitro PKA phosphorylation assay, in vitro GEP activity assay, recombinant phosphatase treatment, co-immunoprecipitation from microsomal fractions","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic assay with phosphatase reversal, specific PP1γ identified by Co-IP","pmids":["17360629"],"is_preprint":false},{"year":2007,"finding":"BIG2 forms homodimers through interactions between DCB domains and between DCB and HUS domains within the N-terminal region, mediated by the conserved HUS box; this dimeric DCB-HUS structural unit is shared across GBF and BIG ArfGEF subfamilies and is proposed to have a regulatory role in Arf activation.","method":"Yeast two-hybrid, biochemical pulldown assays, cellular dimerization assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal biochemical assays (yeast two-hybrid plus in vitro pulldown), but functional consequence of dimerization not directly tested for BIG2","pmids":["17640864"],"is_preprint":false},{"year":2008,"finding":"BIG2 anchors PKA regulatory subunit RIIβ via AKAP domains B and C to mediate cAMP-induced PKA-dependent release of TNFR1 exosome-like vesicles. RIIβ knockdown reduces both constitutive and cAMP-induced TNFR1 exosome-like vesicle release.","method":"siRNA knockdown of individual PKA regulatory subunits, cAMP stimulation, TNFR1 vesicle release assay, domain mapping","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — specific siRNA epistasis with functional assay, AKAP domain mapping confirmed","pmids":["18625701"],"is_preprint":false},{"year":2008,"finding":"Simultaneous RNAi knockdown of both BIG2 and BIG1 causes mislocalization of TGN/recycling endosome-associated proteins and blocks retrograde transport of furin from late endosomes to the TGN; single knockdown of either alone has less severe effects, indicating redundant roles in AP-1-dependent TGN–endosome trafficking.","method":"Double RNAi knockdown, immunofluorescence for cargo proteins, furin retrograde transport assay","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — double knockdown with specific cargo transport readout, epistasis with AP-1","pmids":["18417613"],"is_preprint":false},{"year":2009,"finding":"PDE3A interacts with BIG1 and BIG2 (as components of their AKAP scaffolding complexes); selective PDE3A depletion or inhibition by cilostamide decreases membrane-associated BIG1 and BIG2 and reduces activated ARF1-GTP levels, suggesting PDE3A limits local cAMP that would otherwise drive PKA-mediated inhibition of BIG GEP activity.","method":"siRNA knockdown of PDE3A, PDE3A inhibitor (cilostamide), confocal immunofluorescence, ARF1-GTP pulldown","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological plus siRNA approach with ARF1-GTP measurement, single lab study","pmids":["19332778"],"is_preprint":false},{"year":2010,"finding":"BIG2 is essential for early mouse embryonic development; homozygous Arfgef2 gene-trap disruption causes lethality before the 4-cell stage. Arfgef2 mRNA is maternally stored in oocytes and the embryonic gene is activated at the 4-cell stage.","method":"Gene-trap mouse line, breeding analysis, LacZ reporter expression, SNP markers for embryo genotyping","journal":"The International journal of developmental biology","confidence":"High","confidence_rationale":"Tier 2 — complete loss-of-function in mouse with defined stage of lethality and expression timing","pmids":["20357875"],"is_preprint":false},{"year":2010,"finding":"BIG2 depletion by siRNA specifically induces tubulation of recycling endosomes (distinct from BIG1 depletion, which fragments the Golgi), demonstrating non-redundant roles: BIG2 is specifically required for endosomal compartment integrity.","method":"siRNA knockdown, fixed and live-cell imaging, organelle marker analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — direct comparative siRNA study with live and fixed imaging, replicates and extends earlier findings","pmids":["20360857"],"is_preprint":false},{"year":2012,"finding":"Arl1 (an Arf-like GTPase) is necessary for Golgi recruitment of BIG2 and BIG1 to the trans-Golgi (but not for GBF1 recruitment); Arl1 binds directly to the N-terminal region of BIG2/BIG1 orthologs, directing trans-Golgi-specific ARF1 GEF activity.","method":"Liposome-based affinity purification, Arl1 knockdown in mammalian cells, immunofluorescence for BIG1/BIG2 Golgi localization","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1–2 — reconstitution on liposomes plus genetic knockdown with localization readout","pmids":["22291037"],"is_preprint":false},{"year":2012,"finding":"BIG2 regulates cell migration by controlling integrin β1 recycling to the cell surface and actin remodeling. BIG2 siRNA causes perinuclear accumulation of integrin β1, increases cytosolic Arp2/3, cofilin, and vinculin levels, decreases membrane protrusions at leading edges, and impairs wound-healing migration.","method":"siRNA knockdown, DIGE proteomics, immunofluorescence, wound-healing assay, integrin β1 surface trafficking assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — siRNA with multiple orthogonal readouts (proteomics, localization, functional migration assay)","pmids":["22908276"],"is_preprint":false},{"year":2013,"finding":"GBF1-activated ARF4 and ARF5 (but not ARF3) facilitate BIG1 and BIG2 recruitment to the TGN, establishing a functional GEF cascade where GBF1 acts upstream of BIG1/BIG2 in the Golgi/TGN system.","method":"GBF1 depletion, dominant-negative GBF1, ARF isoform-specific knockdown, immunofluorescence for BIG1/BIG2 localization, ultrastructural localization of GBF1","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple siRNA and dominant-negative experiments with ARF isoform epistasis and localization readouts","pmids":["23386609"],"is_preprint":false},{"year":2013,"finding":"BIG1 and BIG2 anchor myosin phosphatase complexes (comprising myosin IIA, protein phosphatase 1δ, and myosin phosphatase-targeting subunit 1) independently of their ARF-GEF catalytic activity. Depletion of BIG1 or BIG2 enhances myosin regulatory light chain phosphorylation (T18/S19) and F-actin content, impairing cell migration; these effects are rescued by overexpression of the BIG C-terminal sequence lacking GEF activity.","method":"Reciprocal co-immunoprecipitation of endogenous proteins, siRNA depletion, rescue with C-terminal domain overexpression, myosin light chain phosphorylation assay, Transwell migration assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 — reciprocal Co-IP of endogenous complex, GEF-independent rescue, functional migration assay","pmids":["23918382"],"is_preprint":false},{"year":2016,"finding":"BIG2 co-immunoprecipitates with β-catenin; BIG2 depletion or expression of GEF-inactive mutant causes β-catenin accumulation at perinuclear Golgi structures. BIG2 AKAP-C domain is required for PKA-mediated phosphorylation of β-catenin at S675 and for β-catenin transcription coactivator function, requiring both phospholipase D activity and vesicular trafficking.","method":"Co-immunoprecipitation, siRNA depletion, GEF-inactive mutant overexpression, β-catenin S675 phosphorylation assay, transcriptional reporter assay, AKAP domain deletion","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — Co-IP, domain mapping, phosphorylation assay, and functional transcription readout in same study","pmids":["27162341"],"is_preprint":false},{"year":2018,"finding":"BIG2 activates ARF1 in hippocampal neurons to promote dendritic Golgi polarization and dendrite growth and maintenance through a BIG2→ARF1→RhoA→mDia1 signaling axis. Constitutively active ARF1 Q71L rescues BIG2-null dendritic morphogenesis defects, and BIG2+ARF1 co-overexpression activates RhoA; mDia1 was identified as the downstream effector.","method":"siRNA/shRNA knockdown, constitutively active ARF1 rescue, RhoA activation assay, co-localization immunofluorescence, in utero electroporation, live-cell imaging of dendritic Golgi","journal":"Molecular neurobiology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis (constitutively active ARF1 rescue), RhoA activity assay, in vivo validation by electroporation","pmids":["29455446"],"is_preprint":false},{"year":2006,"finding":"BIG2 protein is most strongly expressed in neural progenitors along the neuroependymal lining of the ventricular zone during development; dominant-negative ARFGEF2 transfection in neuroblastoma cells partially blocks FLNA transport from the Golgi apparatus to the cell membrane, suggesting BIG2 mediates targeted transport of Filamin A to the cell surface in neural progenitors.","method":"Immunohistochemistry, in situ hybridization, western blot, dominant-negative transfection with immunofluorescence for FLNA localization","journal":"The Journal of comparative neurology","confidence":"Medium","confidence_rationale":"Tier 3 — dominant-negative with single cargo readout, limited mechanistic follow-up","pmids":["16320251"],"is_preprint":false},{"year":2025,"finding":"The Drosophila ARFGEF2 ortholog Sec71 (together with Arf1) controls asymmetric division of neural stem cells by facilitating localization of myosin II regulatory light chain (Sqh) to the NSC cortex, dependent on PI(4)P production. Arf1 physically associates with Sqh and the PITP Vibrator, and Arf1/Sec71 facilitate PI(4)P localization to the neuroblast cortex.","method":"Genetic epistasis in Drosophila, co-immunoprecipitation of Arf1 with Sqh and Vibrator, PI(4)P localization by immunofluorescence, neuroblast polarity assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — ortholog study in Drosophila with Co-IP and genetic epistasis, single study","pmids":["40208939"],"is_preprint":false}],"current_model":"ARFGEF2/BIG2 is a large (~200 kDa) brefeldin A-sensitive guanine nucleotide-exchange factor (GEF) that activates class I ARFs (ARF1, ARF3) at the trans-Golgi network and recycling endosomes by accelerating GDP-to-GTP exchange; it recruits AP-1 and GGA coat proteins to the TGN (but not COPI), maintains recycling endosome structural integrity, and also functions as an AKAP scaffold—anchoring PKA regulatory subunits and PP1γ to regulate its own GEP activity and downstream signaling—and, independently of its catalytic activity, scaffolds myosin phosphatase complexes to control actin dynamics, integrin recycling, and directed cell migration, while in neurons it acts through an ARF1→RhoA→mDia1 axis to polarize dendritic Golgi and support dendrite morphogenesis."},"narrative":{"teleology":[{"year":2002,"claim":"BIG2 was placed specifically in TGN-to-endosome trafficking by showing it recruits AP-1 and GGA coat proteins—but not COPI—to TGN membranes through ARF activation, resolving which coat pathways depend on this GEF.","evidence":"BIG2 overexpression and dominant-negative mutant expression with immunofluorescence for AP-1, GGA1, and COPI in mammalian cells","pmids":["11777925","12051703"],"confidence":"High","gaps":["Direct binding between BIG2 and coat adaptors not demonstrated","Cargo specificity of BIG2 versus BIG1 at TGN not resolved"]},{"year":2003,"claim":"BIG2 was identified as a dual-function molecule—an ARF-GEF and an AKAP scaffold—with three distinct PKA regulatory subunit-binding domains, establishing a direct link between cAMP/PKA signaling and vesicular trafficking machinery.","evidence":"Yeast two-hybrid, reciprocal co-immunoprecipitation of endogenous RIα, deletion mapping of AKAP domains A/B/C, subcellular fractionation showing cAMP-induced membrane translocation","pmids":["12571360"],"confidence":"High","gaps":["Functional consequences of PKA binding for ARF activation not yet tested","Which AKAP domain is most physiologically relevant unclear"]},{"year":2003,"claim":"ARFGEF2 mutations were linked to periventricular heterotopia with microcephaly, and BIG2 inhibition was shown to disrupt E-cadherin/β-catenin surface transport in neural progenitors, connecting vesicle trafficking to brain development.","evidence":"Human genetic analysis, dominant-negative ARFGEF2 cDNA transfection, BFA treatment, immunofluorescence in neural cell lines","pmids":["14647276"],"confidence":"High","gaps":["Precise cargo sorting step affected in neural progenitors not defined","Whether E-cadherin mislocalization is sufficient to explain the human malformation not tested"]},{"year":2004,"claim":"BIG2 was shown to localize to recycling endosomes in addition to TGN and to activate ARF1 and ARF3 specifically, with catalytic-dead mutant and ARF knockdown epistasis demonstrating that BIG2 maintains recycling endosome structural integrity through class I ARF activation.","evidence":"E738K catalytic mutant expression, ARF1/ARF3 knockdown, organelle morphology analysis","pmids":["15385626"],"confidence":"High","gaps":["Mechanism by which ARF-GTP maintains endosomal membrane stability not resolved","Whether BIG2 acts on ARF1 and ARF3 sequentially or independently unknown"]},{"year":2006,"claim":"BIG2 was shown to have non-redundant endosomal functions distinct from BIG1: BIG2 specifically supports transferrin receptor recycling from endosomes, while expression studies placed it prominently in neural progenitors where it mediates Filamin A surface transport.","evidence":"Comparative siRNA knockdown of BIG1/BIG2 with transferrin recycling assay; immunohistochemistry and dominant-negative transfection in neuroblastoma cells","pmids":["16477018","16320251"],"confidence":"High","gaps":["Whether BIG2 directly sorts TfnR or acts indirectly through membrane architecture unknown","FLNA transport blocked only partially by dominant-negative"]},{"year":2007,"claim":"The PKA–PP1γ regulatory circuit on BIG2 was biochemically defined: PKA phosphorylation inhibits BIG2 GEF activity, and PP1γ (not PP1α/β or PP2A) specifically reverses this inhibition, establishing a phosphorylation switch controlling ARF activation.","evidence":"In vitro PKA phosphorylation and GEP activity assay, recombinant phosphatase panel, co-immunoprecipitation of endogenous PP1γ from microsomes","pmids":["17360629"],"confidence":"High","gaps":["Phosphorylation site(s) on BIG2 not mapped","In vivo relevance of the phospho-switch not demonstrated"]},{"year":2007,"claim":"BIG2 was found to control TNFR1 exosome-like vesicle release through ARF1/ARF3 and to homodimerize via DCB–HUS domain interactions, adding exosome biogenesis as a BIG2-regulated process and revealing a conserved dimerization architecture.","evidence":"siRNA knockdown with TNFR1 vesicle release assay, ARF knockdown epistasis; yeast two-hybrid and biochemical pulldown for dimerization","pmids":["17276987","17640864"],"confidence":"High","gaps":["Functional requirement for dimerization in vesicle release untested","Whether BIG2 acts at MVB or earlier compartment for TNFR1 sorting unknown"]},{"year":2008,"claim":"The AKAP scaffolding role was connected to exosome secretion: BIG2 anchors RIIβ via AKAP domains B/C to mediate cAMP/PKA-dependent TNFR1 exosome-like vesicle release, while double BIG1/BIG2 knockdown revealed partially redundant roles in AP-1-dependent TGN–endosome transport of furin.","evidence":"Individual PKA regulatory subunit siRNA with TNFR1 vesicle release assay; double BIG1/BIG2 knockdown with furin retrograde transport assay","pmids":["18625701","18417613"],"confidence":"High","gaps":["Relative contribution of BIG2 GEF versus scaffold function to exosome release unclear","Redundancy boundaries between BIG1 and BIG2 for different cargoes not systematically mapped"]},{"year":2012,"claim":"Upstream regulators of BIG2 TGN targeting were identified: Arl1 directly binds BIG2's N-terminus to recruit it to the trans-Golgi, and GBF1-activated ARF4/ARF5 facilitate BIG1/BIG2 TGN recruitment, establishing a GEF cascade (GBF1→ARF4/5→BIG2 recruitment→ARF1 activation).","evidence":"Liposome affinity purification for Arl1 binding; GBF1/ARF isoform-specific knockdown with BIG2 localization readouts","pmids":["22291037","23386609"],"confidence":"High","gaps":["Whether Arl1 and ARF4/5 pathways converge or represent parallel recruitment mechanisms unknown","Structural basis of Arl1–BIG2 interaction not resolved"]},{"year":2013,"claim":"A GEF-independent scaffolding function was established: BIG2 anchors myosin phosphatase complexes (myosin IIA, PP1δ, MYPT1) through its C-terminal region, controlling myosin light chain phosphorylation, actin dynamics, and cell migration independently of ARF activation.","evidence":"Reciprocal co-immunoprecipitation of endogenous proteins, rescue with C-terminal domain lacking GEF activity, Transwell migration assay","pmids":["23918382"],"confidence":"High","gaps":["Whether the myosin phosphatase scaffold and AKAP functions operate on the same or distinct BIG2 pools unknown","Structural basis for C-terminal myosin phosphatase binding not defined"]},{"year":2016,"claim":"BIG2 was shown to couple AKAP-scaffolded PKA to β-catenin signaling: the AKAP-C domain enables PKA-mediated β-catenin S675 phosphorylation and transcriptional co-activation, linking BIG2 vesicular trafficking to Wnt pathway output.","evidence":"Co-immunoprecipitation of BIG2 with β-catenin, AKAP domain deletion, β-catenin S675 phosphorylation assay, transcriptional reporter assay","pmids":["27162341"],"confidence":"High","gaps":["Whether β-catenin phosphorylation occurs at a specific membrane compartment unknown","Contribution of PLD activity versus ARF-GTP to β-catenin signaling not fully dissected"]},{"year":2018,"claim":"In neurons, BIG2 was placed in a linear signaling axis—BIG2→ARF1→RhoA→mDia1—that polarizes dendritic Golgi outposts and supports dendrite growth, with constitutively active ARF1 rescuing BIG2-null phenotypes.","evidence":"siRNA/shRNA knockdown, constitutively active ARF1 Q71L rescue, RhoA activation assay, in utero electroporation, live-cell imaging","pmids":["29455446"],"confidence":"High","gaps":["How BIG2 is selectively activated in dendrites versus axons unknown","Whether RhoA/mDia1 axis operates independently of the myosin phosphatase scaffold function unclear"]},{"year":2025,"claim":"Conservation of the ARF-GEF/Arf1 axis in neural stem cell polarity was demonstrated in Drosophila, where the BIG2 ortholog Sec71 with Arf1 controls myosin II cortical localization via PI(4)P, extending BIG2 function to asymmetric cell division.","evidence":"Genetic epistasis in Drosophila neuroblasts, co-immunoprecipitation of Arf1 with Sqh and Vibrator, PI(4)P localization assays","pmids":["40208939"],"confidence":"Medium","gaps":["Whether mammalian BIG2 similarly controls asymmetric division in neural progenitors untested","Mechanism linking PI(4)P to myosin II cortical recruitment not fully defined"]},{"year":null,"claim":"Key unresolved questions include the structural basis of BIG2 regulation (no high-resolution structure of full-length BIG2), the precise PKA phosphorylation site(s) controlling GEF activity in vivo, and how the AKAP scaffold, myosin phosphatase scaffold, and ARF-GEF functions are spatiotemporally coordinated across different membrane compartments.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of BIG2 or its regulatory domains","PKA phosphorylation sites on BIG2 not mapped","Spatiotemporal coordination of GEF-dependent and GEF-independent functions at different compartments unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,2,3,9]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[4,11,19,20]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,1,2,5,16]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[3,6,15]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[8]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,1,2,3,6,8,12,17]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,9,11,20,21]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[14,21,22]}],"complexes":["BIG1/BIG2 homodimer","BIG2-PKA-RIIβ AKAP complex","BIG2-myosin phosphatase complex"],"partners":["ARF1","ARF3","PRKAR2B","PPP1CC","EXOC7","ARL1","CTNNB1","MYH9"],"other_free_text":[]},"mechanistic_narrative":"ARFGEF2 (BIG2) is a brefeldin A-sensitive guanine nucleotide-exchange factor that activates class I ARFs (ARF1, ARF3) at the trans-Golgi network and recycling endosomes to drive vesicle coat recruitment, cargo trafficking, and organelle integrity. At the TGN, BIG2 specifically promotes AP-1 and GGA coat protein association (but not COPI) to mediate anterograde and retrograde transport of cargoes including E-cadherin, β-catenin, integrin β1, Filamin A, and TNFR1-containing exosome-like vesicles; at recycling endosomes, it maintains compartment structure and supports transferrin receptor recycling through ARF1/ARF3 activation [PMID:11777925, PMID:12051703, PMID:15385626, PMID:16477018, PMID:22908276]. BIG2 also functions as a multi-domain AKAP scaffold that anchors PKA regulatory subunits (RIα, RIIβ) and PP1γ, coupling cAMP/PKA signaling to regulation of its own GEF activity and to β-catenin phosphorylation-dependent transcriptional co-activation, and independently of catalytic activity scaffolds myosin phosphatase complexes to control actin dynamics and directed cell migration [PMID:12571360, PMID:17360629, PMID:18625701, PMID:23918382, PMID:27162341]. In neurons, BIG2 signals through an ARF1→RhoA→mDia1 axis to polarize dendritic Golgi outposts and support dendrite morphogenesis, and loss-of-function mutations cause the autosomal recessive brain malformation periventricular heterotopia with microcephaly [PMID:14647276, PMID:29455446]."},"prefetch_data":{"uniprot":{"accession":"Q9Y6D5","full_name":"Brefeldin A-inhibited guanine nucleotide-exchange protein 2","aliases":["ADP-ribosylation factor guanine nucleotide-exchange factor 2"],"length_aa":1785,"mass_kda":202.0,"function":"Promotes guanine-nucleotide exchange on ARF1 and ARF3 and to a lower extent on ARF5 and ARF6. Promotes the activation of ARF1/ARF5/ARF6 through replacement of GDP with GTP. Involved in the regulation of Golgi vesicular transport. Required for the integrity of the endosomal compartment. Involved in trafficking from the trans-Golgi network (TGN) to endosomes and is required for membrane association of the AP-1 complex and GGA1. Seems to be involved in recycling of the transferrin receptor from recycling endosomes to the plasma membrane. Probably is involved in the exit of GABA(A) receptors from the endoplasmic reticulum. Involved in constitutive release of tumor necrosis factor receptor 1 via exosome-like vesicles; the function seems to involve PKA and specifically PRKAR2B. Proposed to act as A kinase-anchoring protein (AKAP) and may mediate crosstalk between Arf and PKA pathways","subcellular_location":"Cytoplasm; Membrane; Golgi apparatus; Cytoplasm, perinuclear region; Golgi apparatus, trans-Golgi network; Endosome; Cytoplasm, cytoskeleton, microtubule organizing center, centrosome; Cell projection, dendrite; Cytoplasmic vesicle; Synapse; Cytoplasm, cytoskeleton","url":"https://www.uniprot.org/uniprotkb/Q9Y6D5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ARFGEF2","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000124198","cell_line_id":"CID000660","localizations":[{"compartment":"big_aggregates","grade":3},{"compartment":"golgi","grade":3},{"compartment":"cytoplasmic","grade":1}],"interactors":[{"gene":"AKAP10","stoichiometry":10.0},{"gene":"ARFGEF1","stoichiometry":4.0},{"gene":"MYCBP","stoichiometry":0.2},{"gene":"DPY30","stoichiometry":0.2},{"gene":"CSNK2B","stoichiometry":0.2},{"gene":"PSMC6","stoichiometry":0.2},{"gene":"PSMD13","stoichiometry":0.2},{"gene":"PSMD2","stoichiometry":0.2},{"gene":"PSMD3","stoichiometry":0.2},{"gene":"PSMD4","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000660","total_profiled":1310},"omim":[{"mim_id":"608097","title":"PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM","url":"https://www.omim.org/entry/608097"},{"mim_id":"605371","title":"ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; ARFGEF2","url":"https://www.omim.org/entry/605371"},{"mim_id":"300049","title":"PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1","url":"https://www.omim.org/entry/300049"},{"mim_id":"116806","title":"CATENIN, BETA-1; CTNNB1","url":"https://www.omim.org/entry/116806"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Golgi apparatus","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"parathyroid gland","ntpm":76.7}],"url":"https://www.proteinatlas.org/search/ARFGEF2"},"hgnc":{"alias_symbol":["BIG2"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y6D5","domains":[{"cath_id":"1.10.1000.11","chopping":"736-829","consensus_level":"medium","plddt":86.3972,"start":736,"end":829},{"cath_id":"-","chopping":"983-1011_1062-1146","consensus_level":"medium","plddt":85.7279,"start":983,"end":1146},{"cath_id":"-","chopping":"1548-1591_1599-1773","consensus_level":"medium","plddt":87.4499,"start":1548,"end":1773}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y6D5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y6D5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y6D5-F1-predicted_aligned_error_v6.png","plddt_mean":76.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARFGEF2","jax_strain_url":"https://www.jax.org/strain/search?query=ARFGEF2"},"sequence":{"accession":"Q9Y6D5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y6D5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y6D5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y6D5"}},"corpus_meta":[{"pmid":"14647276","id":"PMC_14647276","title":"Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14647276","citation_count":287,"is_preprint":false},{"pmid":"8586965","id":"PMC_8586965","title":"Overlapping and differential expression of BIG-2, BIG-1, TAG-1, and F3: four members of an axon-associated cell adhesion molecule subgroup of the immunoglobulin superfamily.","date":"1995","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/8586965","citation_count":141,"is_preprint":false},{"pmid":"18367085","id":"PMC_18367085","title":"BIG-2 mediates olfactory axon convergence to target glomeruli.","date":"2008","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/18367085","citation_count":130,"is_preprint":false},{"pmid":"15385626","id":"PMC_15385626","title":"BIG2, a guanine nucleotide exchange factor for ADP-ribosylation factors: its localization to recycling endosomes and implication in the endosome integrity.","date":"2004","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15385626","citation_count":121,"is_preprint":false},{"pmid":"11777925","id":"PMC_11777925","title":"Overexpression of an ADP-ribosylation factor-guanine nucleotide exchange factor, BIG2, uncouples brefeldin A-induced adaptor protein-1 coat dissociation and membrane tubulation.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11777925","citation_count":93,"is_preprint":false},{"pmid":"12571360","id":"PMC_12571360","title":"Protein kinase A-anchoring (AKAP) domains in brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2).","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12571360","citation_count":80,"is_preprint":false},{"pmid":"18417613","id":"PMC_18417613","title":"Redundant roles of BIG2 and BIG1, guanine-nucleotide exchange factors for ADP-ribosylation factors in membrane traffic between the trans-Golgi network and endosomes.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18417613","citation_count":75,"is_preprint":false},{"pmid":"12051703","id":"PMC_12051703","title":"Dominant-negative mutant of BIG2, an ARF-guanine nucleotide exchange factor, specifically affects membrane trafficking from the trans-Golgi network through inhibiting membrane association of AP-1 and GGA coat proteins.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12051703","citation_count":68,"is_preprint":false},{"pmid":"23386609","id":"PMC_23386609","title":"The Sec7 guanine nucleotide exchange factor GBF1 regulates membrane recruitment of BIG1 and BIG2 guanine nucleotide exchange factors to the trans-Golgi network (TGN).","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23386609","citation_count":66,"is_preprint":false},{"pmid":"22291037","id":"PMC_22291037","title":"The small G protein Arl1 directs the trans-Golgi-specific targeting of the Arf1 exchange factors BIG1 and BIG2.","date":"2012","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22291037","citation_count":57,"is_preprint":false},{"pmid":"17276987","id":"PMC_17276987","title":"The brefeldin A-inhibited guanine nucleotide-exchange protein, BIG2, regulates the constitutive release of TNFR1 exosome-like vesicles.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17276987","citation_count":56,"is_preprint":false},{"pmid":"16477018","id":"PMC_16477018","title":"Association of brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2) with recycling endosomes during transferrin uptake.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16477018","citation_count":53,"is_preprint":false},{"pmid":"15705715","id":"PMC_15705715","title":"Interaction of BIG2, a brefeldin A-inhibited guanine nucleotide-exchange protein, with exocyst protein Exo70.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15705715","citation_count":45,"is_preprint":false},{"pmid":"17360629","id":"PMC_17360629","title":"Regulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) and BIG2 activity via PKA and protein phosphatase 1gamma.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17360629","citation_count":44,"is_preprint":false},{"pmid":"17640864","id":"PMC_17640864","title":"Interactions between conserved domains within homodimers in the BIG1, BIG2, and GBF1 Arf guanine nucleotide exchange factors.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17640864","citation_count":43,"is_preprint":false},{"pmid":"16320251","id":"PMC_16320251","title":"Overlapping expression of ARFGEF2 and Filamin A in the neuroependymal lining of the lateral ventricles: insights into the cause of periventricular heterotopia.","date":"2006","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16320251","citation_count":37,"is_preprint":false},{"pmid":"20360857","id":"PMC_20360857","title":"Specific functions of BIG1 and BIG2 in endomembrane organization.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20360857","citation_count":36,"is_preprint":false},{"pmid":"19384555","id":"PMC_19384555","title":"Movement disorder and neuronal migration disorder due to ARFGEF2 mutation.","date":"2009","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19384555","citation_count":30,"is_preprint":false},{"pmid":"29016942","id":"PMC_29016942","title":"BEN3/BIG2 ARF GEF is Involved in Brefeldin A-Sensitive Trafficking at the trans-Golgi Network/Early Endosome in Arabidopsis thaliana.","date":"2017","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29016942","citation_count":27,"is_preprint":false},{"pmid":"18625701","id":"PMC_18625701","title":"cAMP-dependent protein kinase A (PKA) signaling induces TNFR1 exosome-like vesicle release via anchoring of PKA regulatory subunit RIIbeta to BIG2.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18625701","citation_count":26,"is_preprint":false},{"pmid":"23918382","id":"PMC_23918382","title":"Arf guanine nucleotide-exchange factors BIG1 and BIG2 regulate nonmuscle myosin IIA activity by anchoring myosin phosphatase complex.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23918382","citation_count":25,"is_preprint":false},{"pmid":"16866877","id":"PMC_16866877","title":"AMY-1 (associate of Myc-1) localization to the trans-Golgi network through interacting with BIG2, a guanine-nucleotide exchange factor for ADP-ribosylation factors.","date":"2006","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/16866877","citation_count":25,"is_preprint":false},{"pmid":"19332778","id":"PMC_19332778","title":"Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activity.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19332778","citation_count":23,"is_preprint":false},{"pmid":"23812912","id":"PMC_23812912","title":"West syndrome, microcephaly, grey matter heterotopia and hypoplasia of corpus callosum due to a novel ARFGEF2 mutation.","date":"2013","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23812912","citation_count":22,"is_preprint":false},{"pmid":"29455446","id":"PMC_29455446","title":"BIG2-ARF1-RhoA-mDia1 Signaling Regulates Dendritic Golgi Polarization in Hippocampal Neurons.","date":"2018","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/29455446","citation_count":22,"is_preprint":false},{"pmid":"16413271","id":"PMC_16413271","title":"Expression of BIG2 and analysis of its function in mammalian cells.","date":"2005","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/16413271","citation_count":20,"is_preprint":false},{"pmid":"14571131","id":"PMC_14571131","title":"Cloning and characterization of the human neural cell adhesion molecule, CNTN4 (alias BIG-2).","date":"2003","source":"Cytogenetic and genome research","url":"https://pubmed.ncbi.nlm.nih.gov/14571131","citation_count":20,"is_preprint":false},{"pmid":"27162341","id":"PMC_27162341","title":"Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27162341","citation_count":19,"is_preprint":false},{"pmid":"26126837","id":"PMC_26126837","title":"The expanding phenotypic spectrum of ARFGEF2 gene mutation: Cardiomyopathy and movement disorder.","date":"2015","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/26126837","citation_count":19,"is_preprint":false},{"pmid":"25160555","id":"PMC_25160555","title":"Periventricular nodular heterotopia and dystonia due to an ARFGEF2 mutation.","date":"2014","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25160555","citation_count":17,"is_preprint":false},{"pmid":"20857375","id":"PMC_20857375","title":"Early embryonic lethality in gene trap mice with disruption of the Arfgef2 gene.","date":"2010","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20857375","citation_count":17,"is_preprint":false},{"pmid":"25097827","id":"PMC_25097827","title":"Filamin A mediated Big2 dependent endocytosis: From apical abscission to periventricular heterotopia.","date":"2014","source":"Tissue barriers","url":"https://pubmed.ncbi.nlm.nih.gov/25097827","citation_count":16,"is_preprint":false},{"pmid":"16413268","id":"PMC_16413268","title":"BIG1 and BIG2, brefeldin A-inhibited guanine nucleotide-exchange factors for ADP-ribosylation factors.","date":"2005","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/16413268","citation_count":14,"is_preprint":false},{"pmid":"22908276","id":"PMC_22908276","title":"Brefeldin A-inhibited ADP-ribosylation factor activator BIG2 regulates cell migration via integrin β1 cycling and actin remodeling.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22908276","citation_count":14,"is_preprint":false},{"pmid":"23755938","id":"PMC_23755938","title":"Elaborating the phenotypic spectrum associated with mutations in ARFGEF2: case study and literature review.","date":"2013","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/23755938","citation_count":11,"is_preprint":false},{"pmid":"9221934","id":"PMC_9221934","title":"A novel splice variant of the cell adhesion molecule BIG-2 is expressed in the olfactory and vomeronasal neuroepithelia.","date":"1997","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9221934","citation_count":11,"is_preprint":false},{"pmid":"24709996","id":"PMC_24709996","title":"Filamin A and Big2: a shared endocytic pathway.","date":"2014","source":"Bioarchitecture","url":"https://pubmed.ncbi.nlm.nih.gov/24709996","citation_count":9,"is_preprint":false},{"pmid":"31199673","id":"PMC_31199673","title":"Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/31199673","citation_count":9,"is_preprint":false},{"pmid":"21445711","id":"PMC_21445711","title":"Nanomechanics of Ig-like domains of human contactin (BIG-2).","date":"2011","source":"Journal of molecular modeling","url":"https://pubmed.ncbi.nlm.nih.gov/21445711","citation_count":6,"is_preprint":false},{"pmid":"40208939","id":"PMC_40208939","title":"Arf1 and ARFGEF2/Sec71 control neuroblast polarity by anchoring nonmuscle myosin II.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/40208939","citation_count":1,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.03.657768","title":"A conserved Arf-GEF modulates axonal integrity through RAB-35 by altering neuron-epidermal attachment","date":"2025-06-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.03.657768","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.08.06.25333109","title":"Initial findings from the DecodeME genome-wide association study of myalgic encephalomyelitis/chronic fatigue syndrome","date":"2025-08-08","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.06.25333109","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":22049,"output_tokens":6048,"usd":0.078434},"stage2":{"model":"claude-opus-4-6","input_tokens":9745,"output_tokens":3911,"usd":0.21975},"total_usd":0.298184,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"ARFGEF2 encodes BIG2, a brefeldin A-inhibited guanine nucleotide-exchange factor required for vesicle and membrane trafficking from the trans-Golgi network (TGN). Inhibition of BIG2 by BFA or dominant-negative ARFGEF2 cDNA decreases neural progenitor cell proliferation in vitro and disrupts intracellular localization of E-cadherin and beta-catenin by preventing their transport from the Golgi apparatus to the cell surface.\",\n      \"method\": \"Dominant-negative ARFGEF2 cDNA transfection, BFA inhibition, western blot, immunofluorescence in neural cell lines\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (dominant-negative, pharmacological inhibition, localization), replicated phenotypes\",\n      \"pmids\": [\"14647276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"BIG2 overexpression blocks BFA-induced redistribution of ARF1 and the AP-1 complex from membranes but not that of the COPI complex, indicating BIG2 specifically mediates AP-1 (but not COPI) membrane association through ARF activation at the TGN.\",\n      \"method\": \"BIG2 overexpression, BFA treatment, immunofluorescence for coat proteins\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — overexpression plus pharmacological perturbation with specific coat protein readouts, replicated by dominant-negative study\",\n      \"pmids\": [\"11777925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"A dominant-negative BIG2 mutant induces redistribution of AP-1 and GGA1 from membranes and causes TGN membrane tubulation, but does not affect COPI redistribution or Golgi membrane tubulation, placing BIG2 specifically in the TGN-to-endosome trafficking route via AP-1 and GGA coat proteins.\",\n      \"method\": \"Dominant-negative BIG2 mutant expression, immunofluorescence for coat proteins and organelle markers\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — dominant-negative with specific coat protein readouts, consistent with parallel overexpression study\",\n      \"pmids\": [\"12051703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"A population of BIG2 localizes to recycling endosomes (in addition to TGN); expression of a catalytically inactive BIG2 E738K mutant selectively induces membrane tubules from the recycling endosome compartment. BIG2 activates class I ARFs (ARF1 and ARF3) in vivo, and inactivation of either ARF exaggerates E738K-induced tubulation, indicating BIG2 maintains recycling endosome structural integrity through class I ARF activation.\",\n      \"method\": \"Catalytically inactive mutant (E738K) expression, ARF knockdown, immunofluorescence, organelle morphology analysis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — catalytic mutant with defined substrate specificity confirmed in vivo, genetic epistasis with ARF1/ARF3\",\n      \"pmids\": [\"15385626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"BIG2 contains three A kinase-anchoring protein (AKAP) domains: domain A (residues 27–48) interacting with RIα and RIβ, domain B (residues 284–301) interacting with RIIα and RIIβ, and domain C (residues 517–538) interacting with RIα, RIIα, and RIIβ. BIG2 co-immunoprecipitates with endogenous RIα in HepG2 cytosol, and cAMP elevation causes BIG2 translocation from cytosol to Golgi/membrane structures.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation of in vitro translated and endogenous proteins, deletion mutagenesis, subcellular fractionation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — yeast two-hybrid confirmed by reciprocal Co-IP of endogenous proteins plus deletion mapping of three AKAP domains\",\n      \"pmids\": [\"12571360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"BIG2 physically interacts with exocyst protein Exo70 via its N-terminal region (amino acids 1–643). Endogenous BIG2 and Exo70 co-localize at TGN membranes and the microtubule-organizing center (MTOC)/centrosomes in HepG2 cells, suggesting functional cooperation in vesicular trafficking from TGN to plasma membrane.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation of in vitro translated proteins, immunofluorescence, centrosome purification\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid confirmed by Co-IP plus subcellular fractionation/localization\",\n      \"pmids\": [\"15705715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BIG2, but not BIG1, associates with recycling endosomes during transferrin uptake and is required for transferrin receptor (TfnR) recycling. BIG2 siRNA knockdown increases perinuclear TfnR accumulation and slows transferrin release, while BIG1 siRNA has no effect on these processes.\",\n      \"method\": \"siRNA knockdown, immunofluorescence, density-gradient fractionation, transferrin uptake/release assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — specific siRNA knockdown with functional recycling assay and fractionation confirming localization\",\n      \"pmids\": [\"16477018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BIG2 (but not BIG1) is required for AMY-1 localization to the TGN; AMY-1 co-immunoprecipitates with both BIG1 and BIG2, but RNAi knockdown demonstrates that BIG2 specifically anchors AMY-1 at the TGN.\",\n      \"method\": \"Co-immunoprecipitation with FLAG-tagged AMY-1, RNAi knockdown, immunofluorescence\",\n      \"journal\": \"Genes to cells : devoted to molecular & cellular mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP with RNAi confirmation, single study\",\n      \"pmids\": [\"16866877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BIG2 (but not BIG1) regulates the constitutive release of full-length TNFR1 in exosome-like vesicles from human vascular endothelial cells via ARF1- and ARF3-dependent mechanisms. BIG2 co-localizes with TNFR1 in cytoplasmic vesicles and this association is disrupted by BFA.\",\n      \"method\": \"RNAi knockdown of BIG1/BIG2, TNFR1 release assay, ARF1/ARF3 knockdown, co-localization immunofluorescence, BFA treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — specific siRNA with functional exosome release assay, ARF substrate confirmed by knockdown epistasis\",\n      \"pmids\": [\"17276987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PKA phosphorylates BIG2 in vitro (causing electrophoretic retardation), decreasing its ARF guanine nucleotide exchange activity; protein phosphatase 1γ (PP1γ), but not PP1α, PP1β, or PP2A, restores BIG2 GEP activity after PKA phosphorylation. Endogenous PP1γ co-immunoprecipitates with BIG2 from microsomal fractions.\",\n      \"method\": \"In vitro PKA phosphorylation assay, in vitro GEP activity assay, recombinant phosphatase treatment, co-immunoprecipitation from microsomal fractions\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay with phosphatase reversal, specific PP1γ identified by Co-IP\",\n      \"pmids\": [\"17360629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BIG2 forms homodimers through interactions between DCB domains and between DCB and HUS domains within the N-terminal region, mediated by the conserved HUS box; this dimeric DCB-HUS structural unit is shared across GBF and BIG ArfGEF subfamilies and is proposed to have a regulatory role in Arf activation.\",\n      \"method\": \"Yeast two-hybrid, biochemical pulldown assays, cellular dimerization assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical assays (yeast two-hybrid plus in vitro pulldown), but functional consequence of dimerization not directly tested for BIG2\",\n      \"pmids\": [\"17640864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BIG2 anchors PKA regulatory subunit RIIβ via AKAP domains B and C to mediate cAMP-induced PKA-dependent release of TNFR1 exosome-like vesicles. RIIβ knockdown reduces both constitutive and cAMP-induced TNFR1 exosome-like vesicle release.\",\n      \"method\": \"siRNA knockdown of individual PKA regulatory subunits, cAMP stimulation, TNFR1 vesicle release assay, domain mapping\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — specific siRNA epistasis with functional assay, AKAP domain mapping confirmed\",\n      \"pmids\": [\"18625701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Simultaneous RNAi knockdown of both BIG2 and BIG1 causes mislocalization of TGN/recycling endosome-associated proteins and blocks retrograde transport of furin from late endosomes to the TGN; single knockdown of either alone has less severe effects, indicating redundant roles in AP-1-dependent TGN–endosome trafficking.\",\n      \"method\": \"Double RNAi knockdown, immunofluorescence for cargo proteins, furin retrograde transport assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — double knockdown with specific cargo transport readout, epistasis with AP-1\",\n      \"pmids\": [\"18417613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PDE3A interacts with BIG1 and BIG2 (as components of their AKAP scaffolding complexes); selective PDE3A depletion or inhibition by cilostamide decreases membrane-associated BIG1 and BIG2 and reduces activated ARF1-GTP levels, suggesting PDE3A limits local cAMP that would otherwise drive PKA-mediated inhibition of BIG GEP activity.\",\n      \"method\": \"siRNA knockdown of PDE3A, PDE3A inhibitor (cilostamide), confocal immunofluorescence, ARF1-GTP pulldown\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological plus siRNA approach with ARF1-GTP measurement, single lab study\",\n      \"pmids\": [\"19332778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"BIG2 is essential for early mouse embryonic development; homozygous Arfgef2 gene-trap disruption causes lethality before the 4-cell stage. Arfgef2 mRNA is maternally stored in oocytes and the embryonic gene is activated at the 4-cell stage.\",\n      \"method\": \"Gene-trap mouse line, breeding analysis, LacZ reporter expression, SNP markers for embryo genotyping\",\n      \"journal\": \"The International journal of developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — complete loss-of-function in mouse with defined stage of lethality and expression timing\",\n      \"pmids\": [\"20357875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"BIG2 depletion by siRNA specifically induces tubulation of recycling endosomes (distinct from BIG1 depletion, which fragments the Golgi), demonstrating non-redundant roles: BIG2 is specifically required for endosomal compartment integrity.\",\n      \"method\": \"siRNA knockdown, fixed and live-cell imaging, organelle marker analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct comparative siRNA study with live and fixed imaging, replicates and extends earlier findings\",\n      \"pmids\": [\"20360857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Arl1 (an Arf-like GTPase) is necessary for Golgi recruitment of BIG2 and BIG1 to the trans-Golgi (but not for GBF1 recruitment); Arl1 binds directly to the N-terminal region of BIG2/BIG1 orthologs, directing trans-Golgi-specific ARF1 GEF activity.\",\n      \"method\": \"Liposome-based affinity purification, Arl1 knockdown in mammalian cells, immunofluorescence for BIG1/BIG2 Golgi localization\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstitution on liposomes plus genetic knockdown with localization readout\",\n      \"pmids\": [\"22291037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BIG2 regulates cell migration by controlling integrin β1 recycling to the cell surface and actin remodeling. BIG2 siRNA causes perinuclear accumulation of integrin β1, increases cytosolic Arp2/3, cofilin, and vinculin levels, decreases membrane protrusions at leading edges, and impairs wound-healing migration.\",\n      \"method\": \"siRNA knockdown, DIGE proteomics, immunofluorescence, wound-healing assay, integrin β1 surface trafficking assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA with multiple orthogonal readouts (proteomics, localization, functional migration assay)\",\n      \"pmids\": [\"22908276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GBF1-activated ARF4 and ARF5 (but not ARF3) facilitate BIG1 and BIG2 recruitment to the TGN, establishing a functional GEF cascade where GBF1 acts upstream of BIG1/BIG2 in the Golgi/TGN system.\",\n      \"method\": \"GBF1 depletion, dominant-negative GBF1, ARF isoform-specific knockdown, immunofluorescence for BIG1/BIG2 localization, ultrastructural localization of GBF1\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple siRNA and dominant-negative experiments with ARF isoform epistasis and localization readouts\",\n      \"pmids\": [\"23386609\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BIG1 and BIG2 anchor myosin phosphatase complexes (comprising myosin IIA, protein phosphatase 1δ, and myosin phosphatase-targeting subunit 1) independently of their ARF-GEF catalytic activity. Depletion of BIG1 or BIG2 enhances myosin regulatory light chain phosphorylation (T18/S19) and F-actin content, impairing cell migration; these effects are rescued by overexpression of the BIG C-terminal sequence lacking GEF activity.\",\n      \"method\": \"Reciprocal co-immunoprecipitation of endogenous proteins, siRNA depletion, rescue with C-terminal domain overexpression, myosin light chain phosphorylation assay, Transwell migration assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reciprocal Co-IP of endogenous complex, GEF-independent rescue, functional migration assay\",\n      \"pmids\": [\"23918382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BIG2 co-immunoprecipitates with β-catenin; BIG2 depletion or expression of GEF-inactive mutant causes β-catenin accumulation at perinuclear Golgi structures. BIG2 AKAP-C domain is required for PKA-mediated phosphorylation of β-catenin at S675 and for β-catenin transcription coactivator function, requiring both phospholipase D activity and vesicular trafficking.\",\n      \"method\": \"Co-immunoprecipitation, siRNA depletion, GEF-inactive mutant overexpression, β-catenin S675 phosphorylation assay, transcriptional reporter assay, AKAP domain deletion\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, domain mapping, phosphorylation assay, and functional transcription readout in same study\",\n      \"pmids\": [\"27162341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BIG2 activates ARF1 in hippocampal neurons to promote dendritic Golgi polarization and dendrite growth and maintenance through a BIG2→ARF1→RhoA→mDia1 signaling axis. Constitutively active ARF1 Q71L rescues BIG2-null dendritic morphogenesis defects, and BIG2+ARF1 co-overexpression activates RhoA; mDia1 was identified as the downstream effector.\",\n      \"method\": \"siRNA/shRNA knockdown, constitutively active ARF1 rescue, RhoA activation assay, co-localization immunofluorescence, in utero electroporation, live-cell imaging of dendritic Golgi\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis (constitutively active ARF1 rescue), RhoA activity assay, in vivo validation by electroporation\",\n      \"pmids\": [\"29455446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BIG2 protein is most strongly expressed in neural progenitors along the neuroependymal lining of the ventricular zone during development; dominant-negative ARFGEF2 transfection in neuroblastoma cells partially blocks FLNA transport from the Golgi apparatus to the cell membrane, suggesting BIG2 mediates targeted transport of Filamin A to the cell surface in neural progenitors.\",\n      \"method\": \"Immunohistochemistry, in situ hybridization, western blot, dominant-negative transfection with immunofluorescence for FLNA localization\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — dominant-negative with single cargo readout, limited mechanistic follow-up\",\n      \"pmids\": [\"16320251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The Drosophila ARFGEF2 ortholog Sec71 (together with Arf1) controls asymmetric division of neural stem cells by facilitating localization of myosin II regulatory light chain (Sqh) to the NSC cortex, dependent on PI(4)P production. Arf1 physically associates with Sqh and the PITP Vibrator, and Arf1/Sec71 facilitate PI(4)P localization to the neuroblast cortex.\",\n      \"method\": \"Genetic epistasis in Drosophila, co-immunoprecipitation of Arf1 with Sqh and Vibrator, PI(4)P localization by immunofluorescence, neuroblast polarity assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ortholog study in Drosophila with Co-IP and genetic epistasis, single study\",\n      \"pmids\": [\"40208939\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARFGEF2/BIG2 is a large (~200 kDa) brefeldin A-sensitive guanine nucleotide-exchange factor (GEF) that activates class I ARFs (ARF1, ARF3) at the trans-Golgi network and recycling endosomes by accelerating GDP-to-GTP exchange; it recruits AP-1 and GGA coat proteins to the TGN (but not COPI), maintains recycling endosome structural integrity, and also functions as an AKAP scaffold—anchoring PKA regulatory subunits and PP1γ to regulate its own GEP activity and downstream signaling—and, independently of its catalytic activity, scaffolds myosin phosphatase complexes to control actin dynamics, integrin recycling, and directed cell migration, while in neurons it acts through an ARF1→RhoA→mDia1 axis to polarize dendritic Golgi and support dendrite morphogenesis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ARFGEF2 (BIG2) is a brefeldin A-sensitive guanine nucleotide-exchange factor that activates class I ARFs (ARF1, ARF3) at the trans-Golgi network and recycling endosomes to drive vesicle coat recruitment, cargo trafficking, and organelle integrity. At the TGN, BIG2 specifically promotes AP-1 and GGA coat protein association (but not COPI) to mediate anterograde and retrograde transport of cargoes including E-cadherin, β-catenin, integrin β1, Filamin A, and TNFR1-containing exosome-like vesicles; at recycling endosomes, it maintains compartment structure and supports transferrin receptor recycling through ARF1/ARF3 activation [PMID:11777925, PMID:12051703, PMID:15385626, PMID:16477018, PMID:22908276]. BIG2 also functions as a multi-domain AKAP scaffold that anchors PKA regulatory subunits (RIα, RIIβ) and PP1γ, coupling cAMP/PKA signaling to regulation of its own GEF activity and to β-catenin phosphorylation-dependent transcriptional co-activation, and independently of catalytic activity scaffolds myosin phosphatase complexes to control actin dynamics and directed cell migration [PMID:12571360, PMID:17360629, PMID:18625701, PMID:23918382, PMID:27162341]. In neurons, BIG2 signals through an ARF1→RhoA→mDia1 axis to polarize dendritic Golgi outposts and support dendrite morphogenesis, and loss-of-function mutations cause the autosomal recessive brain malformation periventricular heterotopia with microcephaly [PMID:14647276, PMID:29455446].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"BIG2 was placed specifically in TGN-to-endosome trafficking by showing it recruits AP-1 and GGA coat proteins—but not COPI—to TGN membranes through ARF activation, resolving which coat pathways depend on this GEF.\",\n      \"evidence\": \"BIG2 overexpression and dominant-negative mutant expression with immunofluorescence for AP-1, GGA1, and COPI in mammalian cells\",\n      \"pmids\": [\"11777925\", \"12051703\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding between BIG2 and coat adaptors not demonstrated\", \"Cargo specificity of BIG2 versus BIG1 at TGN not resolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"BIG2 was identified as a dual-function molecule—an ARF-GEF and an AKAP scaffold—with three distinct PKA regulatory subunit-binding domains, establishing a direct link between cAMP/PKA signaling and vesicular trafficking machinery.\",\n      \"evidence\": \"Yeast two-hybrid, reciprocal co-immunoprecipitation of endogenous RIα, deletion mapping of AKAP domains A/B/C, subcellular fractionation showing cAMP-induced membrane translocation\",\n      \"pmids\": [\"12571360\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequences of PKA binding for ARF activation not yet tested\", \"Which AKAP domain is most physiologically relevant unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"ARFGEF2 mutations were linked to periventricular heterotopia with microcephaly, and BIG2 inhibition was shown to disrupt E-cadherin/β-catenin surface transport in neural progenitors, connecting vesicle trafficking to brain development.\",\n      \"evidence\": \"Human genetic analysis, dominant-negative ARFGEF2 cDNA transfection, BFA treatment, immunofluorescence in neural cell lines\",\n      \"pmids\": [\"14647276\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise cargo sorting step affected in neural progenitors not defined\", \"Whether E-cadherin mislocalization is sufficient to explain the human malformation not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"BIG2 was shown to localize to recycling endosomes in addition to TGN and to activate ARF1 and ARF3 specifically, with catalytic-dead mutant and ARF knockdown epistasis demonstrating that BIG2 maintains recycling endosome structural integrity through class I ARF activation.\",\n      \"evidence\": \"E738K catalytic mutant expression, ARF1/ARF3 knockdown, organelle morphology analysis\",\n      \"pmids\": [\"15385626\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which ARF-GTP maintains endosomal membrane stability not resolved\", \"Whether BIG2 acts on ARF1 and ARF3 sequentially or independently unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"BIG2 was shown to have non-redundant endosomal functions distinct from BIG1: BIG2 specifically supports transferrin receptor recycling from endosomes, while expression studies placed it prominently in neural progenitors where it mediates Filamin A surface transport.\",\n      \"evidence\": \"Comparative siRNA knockdown of BIG1/BIG2 with transferrin recycling assay; immunohistochemistry and dominant-negative transfection in neuroblastoma cells\",\n      \"pmids\": [\"16477018\", \"16320251\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether BIG2 directly sorts TfnR or acts indirectly through membrane architecture unknown\", \"FLNA transport blocked only partially by dominant-negative\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The PKA–PP1γ regulatory circuit on BIG2 was biochemically defined: PKA phosphorylation inhibits BIG2 GEF activity, and PP1γ (not PP1α/β or PP2A) specifically reverses this inhibition, establishing a phosphorylation switch controlling ARF activation.\",\n      \"evidence\": \"In vitro PKA phosphorylation and GEP activity assay, recombinant phosphatase panel, co-immunoprecipitation of endogenous PP1γ from microsomes\",\n      \"pmids\": [\"17360629\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation site(s) on BIG2 not mapped\", \"In vivo relevance of the phospho-switch not demonstrated\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"BIG2 was found to control TNFR1 exosome-like vesicle release through ARF1/ARF3 and to homodimerize via DCB–HUS domain interactions, adding exosome biogenesis as a BIG2-regulated process and revealing a conserved dimerization architecture.\",\n      \"evidence\": \"siRNA knockdown with TNFR1 vesicle release assay, ARF knockdown epistasis; yeast two-hybrid and biochemical pulldown for dimerization\",\n      \"pmids\": [\"17276987\", \"17640864\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional requirement for dimerization in vesicle release untested\", \"Whether BIG2 acts at MVB or earlier compartment for TNFR1 sorting unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The AKAP scaffolding role was connected to exosome secretion: BIG2 anchors RIIβ via AKAP domains B/C to mediate cAMP/PKA-dependent TNFR1 exosome-like vesicle release, while double BIG1/BIG2 knockdown revealed partially redundant roles in AP-1-dependent TGN–endosome transport of furin.\",\n      \"evidence\": \"Individual PKA regulatory subunit siRNA with TNFR1 vesicle release assay; double BIG1/BIG2 knockdown with furin retrograde transport assay\",\n      \"pmids\": [\"18625701\", \"18417613\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of BIG2 GEF versus scaffold function to exosome release unclear\", \"Redundancy boundaries between BIG1 and BIG2 for different cargoes not systematically mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Upstream regulators of BIG2 TGN targeting were identified: Arl1 directly binds BIG2's N-terminus to recruit it to the trans-Golgi, and GBF1-activated ARF4/ARF5 facilitate BIG1/BIG2 TGN recruitment, establishing a GEF cascade (GBF1→ARF4/5→BIG2 recruitment→ARF1 activation).\",\n      \"evidence\": \"Liposome affinity purification for Arl1 binding; GBF1/ARF isoform-specific knockdown with BIG2 localization readouts\",\n      \"pmids\": [\"22291037\", \"23386609\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Arl1 and ARF4/5 pathways converge or represent parallel recruitment mechanisms unknown\", \"Structural basis of Arl1–BIG2 interaction not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"A GEF-independent scaffolding function was established: BIG2 anchors myosin phosphatase complexes (myosin IIA, PP1δ, MYPT1) through its C-terminal region, controlling myosin light chain phosphorylation, actin dynamics, and cell migration independently of ARF activation.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation of endogenous proteins, rescue with C-terminal domain lacking GEF activity, Transwell migration assay\",\n      \"pmids\": [\"23918382\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the myosin phosphatase scaffold and AKAP functions operate on the same or distinct BIG2 pools unknown\", \"Structural basis for C-terminal myosin phosphatase binding not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"BIG2 was shown to couple AKAP-scaffolded PKA to β-catenin signaling: the AKAP-C domain enables PKA-mediated β-catenin S675 phosphorylation and transcriptional co-activation, linking BIG2 vesicular trafficking to Wnt pathway output.\",\n      \"evidence\": \"Co-immunoprecipitation of BIG2 with β-catenin, AKAP domain deletion, β-catenin S675 phosphorylation assay, transcriptional reporter assay\",\n      \"pmids\": [\"27162341\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether β-catenin phosphorylation occurs at a specific membrane compartment unknown\", \"Contribution of PLD activity versus ARF-GTP to β-catenin signaling not fully dissected\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"In neurons, BIG2 was placed in a linear signaling axis—BIG2→ARF1→RhoA→mDia1—that polarizes dendritic Golgi outposts and supports dendrite growth, with constitutively active ARF1 rescuing BIG2-null phenotypes.\",\n      \"evidence\": \"siRNA/shRNA knockdown, constitutively active ARF1 Q71L rescue, RhoA activation assay, in utero electroporation, live-cell imaging\",\n      \"pmids\": [\"29455446\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How BIG2 is selectively activated in dendrites versus axons unknown\", \"Whether RhoA/mDia1 axis operates independently of the myosin phosphatase scaffold function unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Conservation of the ARF-GEF/Arf1 axis in neural stem cell polarity was demonstrated in Drosophila, where the BIG2 ortholog Sec71 with Arf1 controls myosin II cortical localization via PI(4)P, extending BIG2 function to asymmetric cell division.\",\n      \"evidence\": \"Genetic epistasis in Drosophila neuroblasts, co-immunoprecipitation of Arf1 with Sqh and Vibrator, PI(4)P localization assays\",\n      \"pmids\": [\"40208939\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether mammalian BIG2 similarly controls asymmetric division in neural progenitors untested\", \"Mechanism linking PI(4)P to myosin II cortical recruitment not fully defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of BIG2 regulation (no high-resolution structure of full-length BIG2), the precise PKA phosphorylation site(s) controlling GEF activity in vivo, and how the AKAP scaffold, myosin phosphatase scaffold, and ARF-GEF functions are spatiotemporally coordinated across different membrane compartments.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of BIG2 or its regulatory domains\", \"PKA phosphorylation sites on BIG2 not mapped\", \"Spatiotemporal coordination of GEF-dependent and GEF-independent functions at different compartments unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 2, 3, 9]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [4, 11, 19, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 1, 2, 5, 16]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [3, 6, 15]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 1, 2, 3, 6, 8, 12, 17]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 9, 11, 20, 21]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [14, 21, 22]}\n    ],\n    \"complexes\": [\n      \"BIG1/BIG2 homodimer\",\n      \"BIG2-PKA-RIIβ AKAP complex\",\n      \"BIG2-myosin phosphatase complex\"\n    ],\n    \"partners\": [\n      \"ARF1\",\n      \"ARF3\",\n      \"PRKAR2B\",\n      \"PPP1CC\",\n      \"EXOC7\",\n      \"ARL1\",\n      \"CTNNB1\",\n      \"MYH9\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}